ATE105563T1 - Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik. - Google Patents

Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.

Info

Publication number
ATE105563T1
ATE105563T1 AT9090400723T AT90400723T ATE105563T1 AT E105563 T1 ATE105563 T1 AT E105563T1 AT 9090400723 T AT9090400723 T AT 9090400723T AT 90400723 T AT90400723 T AT 90400723T AT E105563 T1 ATE105563 T1 AT E105563T1
Authority
AT
Austria
Prior art keywords
human
cladinos
retin
cosmetics
processes
Prior art date
Application number
AT9090400723T
Other languages
English (en)
Inventor
Michel Philippe
Henri Sebag
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE105563T1 publication Critical patent/ATE105563T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
AT9090400723T 1989-03-16 1990-03-16 Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik. ATE105563T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903461A FR2644459B1 (fr) 1989-03-16 1989-03-16 Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
EP90400723A EP0388314B1 (de) 1989-03-16 1990-03-16 Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik

Publications (1)

Publication Number Publication Date
ATE105563T1 true ATE105563T1 (de) 1994-05-15

Family

ID=9379762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9090400723T ATE105563T1 (de) 1989-03-16 1990-03-16 Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.

Country Status (8)

Country Link
US (1) US5096713A (de)
EP (1) EP0388314B1 (de)
JP (1) JPH02268193A (de)
AT (1) ATE105563T1 (de)
CA (1) CA2012218A1 (de)
DE (1) DE69008762T2 (de)
ES (1) ES2052201T3 (de)
FR (1) FR2644459B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
FR2735694B1 (fr) * 1995-06-20 1997-08-08 Roussel Uclaf Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant
US20050239749A1 (en) * 2002-07-25 2005-10-27 Lion Corporation External preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984544A (en) * 1975-02-28 1976-10-05 Schering Corporation Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
KR950014443B1 (ko) * 1986-07-16 1995-11-28 엠. 클리그만 알버트 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases

Also Published As

Publication number Publication date
ES2052201T3 (es) 1994-07-01
FR2644459B1 (fr) 1994-10-28
JPH02268193A (ja) 1990-11-01
US5096713A (en) 1992-03-17
DE69008762D1 (de) 1994-06-16
DE69008762T2 (de) 1994-08-25
EP0388314B1 (de) 1994-05-11
FR2644459A1 (fr) 1990-09-21
EP0388314A1 (de) 1990-09-19
CA2012218A1 (fr) 1990-09-16

Similar Documents

Publication Publication Date Title
GR3026218T3 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
DE69215595D1 (de) Isochinolin-5-yl-Sulfonsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
SE8700498D0 (sv) Novel pharmaceologically active compounds
IL87488A0 (en) Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives
DE3854854D1 (de) 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE59006893D1 (de) Pyrimidin-4,6-dicarbonsäurediamide, Verfahren zu deren Herstellung sowie Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen.
ATE103893T1 (de) 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel.
DE69409337D1 (de) Verzweigte Aminothiazole-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
SE8701406D0 (sv) Aromatiska foreningar, deras framtellningsforfarande och deras anvendning inom human- och veterinermedicinen och inom kosmetiken
AU7896294A (en) New amide-derived biaromatic compounds, pharmaceutical and cosmetic compositions containing them and their uses
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DE69008762D1 (de) Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
IT8368279A0 (it) 5 idrossinaftochinoni per la tintura delle fibre cheratiniche umane procedimento di tintura utilizzante tali composti e composizione tintoria contenente i composti stessi
DE3586194D1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
ATE3634T1 (de) Adamantylalkyloxycarbonylderivate, deren herstellung und verwendung zur darstellung von peptiden.
ATE105564T1 (de) Retinsaeureester von d-desosamin, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.
ATE90095T1 (de) Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE162195T1 (de) 4-hydroxy-phenyl-beta-d-glukose-monoester, verfahren zur ihrer herstellung und ihre verwendung in der kosmetik, der pharmazie, als zahnpflegemitteln und lebensmitteln
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties